Discovery of 3-Chloro-<i>N</i>-{(<i>S</i>)-[3-(1-ethyl-1<i>H</i>-pyrazol-4-yl)phenyl][(2<i>S</i>)-piperidine-2-yl]methyl}-4-(trifluoromethyl)pyridine-2-carboxamide as a Potent Glycine Transporter 1 Inhibitor
Shuji Yamamoto(Taisho Pharmaceutical (Japan)), Hiroshi Kawamoto(Fujita Health University), Yasunori Kawakita(Taisho Pharmaceutical (Japan)), Kumi Abe(Taisho Pharmaceutical (Japan)), Takeshi Aoki(Taisho Pharmaceutical (Japan)), Tsuyoshi Shibata(Sapporo Medical University), Koji Oda(Tokyo Metropolitan University)
Cited by 3
Related Papers
Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience
|Journal of Hepato-Biliary-Pancreatic Surgery|2000|396
Intraductal papillary neoplasia of the liver associated with hepatolithiasis
|Hepatology|2001|282
<scp>l</scp>‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth
|Cancer Science|2009|271
Management of Hilar Cholangiocarcinoma
|Annals of Surgery|2000|259
Surgical Anatomy of the Bile Ducts at the Hepatic Hilum as Applied to Living Donor Liver Transplantation
|Annals of Surgery|2003|203